[1]朱岩,汪军,孟忻,等. 非增殖期糖尿病视网膜病变黄斑水肿对脉络膜横断面面积的影响[J].眼科新进展,2015,35(7):683-685.[doi:10.13389/j.cnki.rao.2015.0187]
 ZHU Yan,WANG Jun,MENG Xin,et al. Effects of macular edema on choroidal cross sec on area in non-proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(7):683-685.[doi:10.13389/j.cnki.rao.2015.0187]
点击复制

 非增殖期糖尿病视网膜病变黄斑水肿对脉络膜横断面面积的影响
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
35卷
期数:
2015年7期
页码:
683-685
栏目:
应用研究
出版日期:
2015-07-05

文章信息/Info

Title:
 Effects of macular edema on choroidal cross sec on area in non-proliferative diabetic retinopathy
作者:
 朱岩汪军孟忻辛晨高新晓刘广峰贾宇颂王华
 100029 北京市,首都医科大学附属北京安贞医院眼科
Author(s):
 ZHU Yan WANG Jun MENG Xin XIN Chen GAO Xin-Xiao LIU Guang-Feng JIA Yu-Song WANG Hua
 Department of Ophthalmology,Beijing Anzhen HospitaL Affiliated to Capital Medical University,Beijing 100029.China
关键词:
 糖尿病视网膜病变黄斑水肿脉络膜横断面面积光学相干断层成像
Keywords:
 diabetic retinopathy macular edema choroidal cross section area optical coherence tomography
DOI:
10.13389/j.cnki.rao.2015.0187
文献标志码:
A
摘要:
 目的 通过光学相干断层成像(opticalcoherencetomography,OCT)分析非增殖期糖尿病视网膜病变黄斑水肿对脉络膜横断面面积的影响。方法 收集2012年3月至2014年2月于我院眼科门诊就诊的非增殖期糖尿病视网膜病变患者47例(57眼),分为非增殖期糖尿病视网膜病变不伴临床显著性黄斑水肿组(NPDRCSME-组)和伴临床显著性黄斑水肿组(NPDRCSME+组)。采用Topcon3DOCT1000脉络膜模式扫描黄斑区,比较2组之间脉络膜横断面面积差异,分析2组脉络膜横断面面积与黄斑中心凹厚度(centralmacularthickness,CMT)、最佳矫正视力的相关性。结果 NPDRCSME-组与NPDRCSME+组性别、年龄和屈光度差异均无统计学意义(P=0.550、0.790、0.070)。NPDRCSME+组脉络膜横断面面积(1141754.47±337762.05)μm2较NPDRCSME-组(1378128.45±395728.66)μm2变小(P=0.019)。NPDRCSME-组脉络膜横断面面积与CMT(中位数226.50μm)之间无相关性(r=-0.130,P=0.494);NPDRCSME+组脉络膜横断面面积与CMT(中位数317.00μm)之间也无相关性(r=-0.218,P=0.274)。NPDRCSME-组脉络膜横断面面积与最佳矫正最小分辨角对数视力(BClogMAR)(中位数0.097)之间无相关性(r=0.321,P=0.080);NPDRCSME+组脉络膜横断面面积与BClogMAR(中位数0.699)之间亦无相关性(r=-0.070,P=0.700)。结论 非增殖期糖尿病视网膜病变患者发生黄斑水肿者较未发生黄斑水肿者脉络膜横断面面积变小。脉络膜横断面面积与CMT、最佳矫正视力均不相关。
Abstract:
 Objective To evaluate the effects of macular edema on choroidal cross section area ( CCSA) in non-proliferative diabetic retinopathy ( NPDR) by optical coherence tomography ( OCT) . Methods Forty-seven persons ( 57 eyes) with NPDR in our hospital from March 2012 to February 2014 were enrolled in this study. They were divided int0 2 groups : NPDR without clinical sigruficant macular edema ( NPDR CSME - ) group , NPDR with clinical significant macular edema ( NPDR CSME + ) group. Choroid beneath the macular was scanned with Topcon 3D OCT 1000 choroidal mode. The differences of CCSA between the two groups were analyzed. Correlation analysis was used between CCSA and central macular thickness ( CMT) . best correct visual acuity, respectively. Results The differences between NPDR CSME - group and NPDR CSME + group rn sex, age and diopter were not statistic significant (P = 0. 550 ,0. 790 . 0. 070 ) . CCSA in NPDR CSME + group was ( 1 141 754. 47 + 337 762. 05 ) Vm2 .which was thinner than CCSA in NPDR CSME - group (1 378 128. 45 + 395 728. 66) pmz (P = 0. 019) . There was no statistic significant correlation between CCSA and CMT neither in NPDR CSME - group ( median was 226. 50 ym) nor in NPDR CSME + group ( median was 317. 00 ym) ( r = - 0. 130 . - 0. 218 ;P = 0. 494 ,0. 274 ) . There was no statistic significant correlation between CCSA and best correct logarithmic nunimum angle of resolution ( BClogMAR) neither in NPDR CSME - group ( median was 0. 097) nor in NPDR CSME + group ( median was 0. 699) ( r = 0. 321 , - 0. 070 ;P = 0. 080 ,0. 700) . Conclusion Presence of macular edema in NPDR is associated with a sigruficant decrease in the CCSA. The CCSA is not related to CMT and best correct visual acuity.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]李琴 谢婷玉 陈雪艺 王清 郭乔茜 具尔提·哈第尔. 臭氧灌肠改善糖尿病大鼠的视网膜电图表现[J].眼科新进展,2014,34(1):034.
[12]蔡晶晶 孟倩丽 郭海科 张良 李东风 崔颖. 血红素加氧酶-1在糖尿病视网膜病变患者外周血单个核细胞中的表达[J].眼科新进展,2014,34(1):037.
[13]张立新 崔颖 孟倩丽 张敏 罗中伶 刘辉焜 朱国平 香淦媚 刘清洋 郭海科 郑洋 蔡晶晶. 广东省东莞市2型糖尿病患者盲与低视力患病率及原因分析[J].眼科新进展,2014,34(1):046.
[14]杨宏伟 韩丁 陈晓隆. 越橘提取物对非增生性糖尿病视网膜病变患者对比敏感度的影响[J].眼科新进展,2014,34(1):065.
[15]徐玲 周小煦 苏畅 吴建国. 超声波提高大鼠视网膜血管消化铺片的效率[J].眼科新进展,2014,34(3):226.
[16]王清 郭乔茜 李琴 谢婷玉 陈雪艺. 臭氧治疗对糖尿病大鼠视网膜细胞凋亡和VEGF、PEDF因子表达的影响[J].眼科新进展,2014,34(3):232.
[17]薛尚才 李惠荣 范勇 温玉 孙建玲. 糖尿病视网膜病变眼轴轴长与中心视网膜厚度的相关性研究[J].眼科新进展,2014,34(3):253.
[18]张敏 崔颖 孟倩丽 刘清洋 张立新 郭海科. 广东省东莞市糖尿病视网膜病变流行病学调查[J].眼科新进展,2014,34(3):260.
[19]陈素芳 曾莉 邵毅. 非诺贝特在糖尿病视网膜病变中的应用进展[J].眼科新进展,2014,34(3):283.
[20]张笃贞,张涤,孙鹏,等. 白藜芦醇对糖尿病大鼠视网膜中SIRT1基因表达的干预作用[J].眼科新进展,2014,34(4):322.[doi:10.13389/j.cnki.rao.2014.0087]

更新日期/Last Update: 2015-07-03